Clinical Safety and Efficacy of CT ASPHINA 509 Lenses

NCT03145116 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 95

Last updated 2018-07-18

No results posted yet for this study

Summary

Clinical safety and efficacy of CT ASPHINA 509 IOLs after implantation

Conditions

  • Cataract

Interventions

DEVICE

CT ASPHINA 509

Intraocular lens

Sponsors & Collaborators

  • Carl Zeiss Meditec AG

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-22
Primary Completion
2018-02-05
Completion
2018-02-05

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03145116 on ClinicalTrials.gov